Newsletter/Booklets 7th Jul 2023

Market Access Barriers in The Pharmaceutical Sector in India’s Key Export Destinations

Authors

Parthsarathi JhaPartner | New Delhi | Noida
Sanjay NotaniPartner | Mumbai
Mitul KaushalConsultant | Delhi NCR
Harika BakarajuPrincipal Associate | Mumbai
Naghm GheiPrincipal Associate | Delhi NCR
Divyashree SuriSenior Associate | Delhi NCR

Latest Thought Leadership

international trades
Alerts & Updates 24th Jul 2026

USTR Finalises Section 301 Forced Labour Tariffs

Read More
Data Privacy
Alerts & Updates 24th Jul 2026

Data Protection Impact Assessments under the DPDP Act, 2023

Read More
Investment Funds
Alerts & Updates 23rd Jul 2026

GARUDA Takes Flight: SEBI’s Shift Towards a Green-Channel Regime for AIFs

Read More
Alerts & Updates 21st Jul 2026

Product Identity and Organoleptic Characteristics: Understanding FSSAI’s recent regulatory focus

Read More

This report examines the regulatory environment of some of India’s key trading partners, with a view to identify existing and potential trade barriers in exporting pharmaceuticals in these markets.  This serves as a ready reckoner and comprehensive guide for the pharmaceutical industry.

Click here

Privacy Policy

As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.